Sign up for a newsletter from aHUS India


In recent months, there have been significant developments in the context of aHUS in India such as the approval of Soliris in India and clinical trials for Crovalimab and Iptacopan. This marks an exciting period for aHUS patients, families, and doctors in India. For many years, there was little positive news regarding this disease in our country, but thankfully, that is changing.

The aHUS India Foundation is launching a newsletter to provide important updates on aHUS developments relevant to India. Given the recent advancements in aHUS treatment and research in India, we believe it is an opportune time to start this initiative. Our newsletter will be sent out approximately every 2-3 months, keeping you informed about the latest news and progress in this field.

If you would like to stay updated on these advancements, please sign up for our newsletter. Rest assured, your email and any other details you provide will remain confidential. It is crucial for us to unite, pool our resources, and advocate for ourselves because no one else will do it for us. Sign up here, and we will keep you informed. Thank you.